Jeonjinbio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	13,694	19,273	15,681	7,794	3,214
Other Revenue	-0	-0	-	-0	-
Revenue	13,694	19,273	15,681	7,794	3,214
Revenue Growth (YoY)	-28.95%	22.91%	101.18%	142.48%	-16.87%
Cost of Revenue	9,952	13,271	10,861	5,836	1,898
Gross Profit	3,742	6,002	4,820	1,958	1,316
Selling, General & Admin	3,426	3,359	3,937	3,346	3,716
Research & Development	438.06	361.75	447.75	421.95	363.84
Amortization of Goodwill & Intangibles	8.16	16.08	20.04	27.15	30.46
Other Operating Expenses	87.52	142.94	134.69	111.8	82.76
Operating Expenses	4,085	4,843	6,065	5,094	4,346
Operating Income	-342.85	1,158	-1,245	-3,136	-3,030
Interest Expense	-0.33	-432.26	-1,195	-2,035	-865.67
Interest & Investment Income	96.47	98.86	115.08	158.71	44.12
Currency Exchange Gain (Loss)	-5.81	6.35	2.71	-25.17	-8.62
Other Non Operating Income (Expenses)	58.78	4,226	-3,564	1,832	1,755
EBT Excluding Unusual Items	-193.74	5,057	-5,886	-3,205	-2,105
Gain (Loss) on Sale of Assets	1.09	-456.58	9.94	-	-2.91
Asset Writedown	-3.16	-254.15	-636.91	-	-
Other Unusual Items	-	-	73.29	91.69	-
Pretax Income	-195.81	4,346	-6,440	-3,113	-2,108
Net Income	-195.81	4,346	-6,440	-3,113	-2,108
Net Income to Common	-195.81	4,346	-6,440	-3,113	-2,108
Shares Outstanding (Basic)	9	9	7	7	6
Shares Outstanding (Diluted)	9	9	7	7	6
Shares Change (YoY)	3.42%	18.14%	10.68%	6.14%	27.16%
EPS (Basic)	-22.00	505.00	-884.03	-473.00	-340.00
EPS (Diluted)	-22.00	505.00	-884.03	-473.00	-340.00
Free Cash Flow	-305.9	2,616	-960.95	-5,705	-4,232
Free Cash Flow Per Share	-34.37	303.93	-131.91	-866.77	-682.57
Gross Margin	27.32%	31.14%	30.74%	25.13%	40.94%
Operating Margin	-2.50%	6.01%	-7.94%	-40.23%	-94.26%
Profit Margin	-1.43%	22.55%	-41.07%	-39.94%	-65.59%
Free Cash Flow Margin	-2.23%	13.57%	-6.13%	-73.19%	-131.67%
EBITDA	192.7	2,500	590.48	-1,744	-2,663
EBITDA Margin	1.41%	12.97%	3.77%	-22.37%	-82.84%
D&A For EBITDA	535.55	1,342	1,835	1,392	367.09
EBIT	-342.85	1,158	-1,245	-3,136	-3,030
EBIT Margin	-2.50%	6.01%	-7.94%	-40.23%	-94.26%
Advertising Expenses	86.01	94.99	219.26	164.76	374.4

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.